The journey to antiretroviral therapy in Karnataka, India: Who was lost on the road?

Journal of the International AIDS Society

Volumn 16, Issue , 2013, Pages

  Shastri, Suresh ^a   Sathyanarayna, Srinath ^b   Nagaraja, Sharath Burugina ^c   Kumar, Ajay M V ^b   Rewari, Bharat ^d   Harries, Anthony D ^b   Zachariah, Rony ^e  

^a Karnataka State AIDS Prevention Society   (India)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c Central TB Division   (India)

^d National AIDS Control Organization   (India)

^e MÉDECINS SANS FRONTIÈRES   (Belgium)

Author keywords

ART centres; India; Loss to follow up; Operational research

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CHI SQUARE TEST; COMMUNITY PROGRAM; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; MIGRATION; NATIONAL AIDS CONTROL PROGRAMME; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ART CENTRES; INDIA; LOSS TO FOLLOW-UP; OPERATIONAL RESEARCH;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INDIA; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; YOUNG ADULT;

EID: 84891549895     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.16.1.18502     Document Type: Article

References (11)

1. UNAIDS. Report UW. Faster. Smarter. Better. 2011.
2. NACO, Mohfw GOI. Technical report, India HIV estimates. New Delhi: Department of AIDS Control, Government of India; 2012.
3. Zachariah R, Tayler-Smith K, Manzi M, Massaquoi M, Mwagomba B, van Griensven J, et al. Retention and attrition during the preparation phase and after start of antiretroviral treatment in Thyolo, Malawi, and Kibera, Kenya: implications for programmes? Trans R Soc Trop Med Hyg. 2011;105(8):421-30.
4. Togun T, Peterson I, Jaffar S, Oko F, Okomo U, Peterson K, et al. Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa. AIDS Res Ther. 2011;8(1):24.
5. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8(7):e1001056.
6. Sogarwal R, Bachani D. Are persons living with HIV timely accessing ART services in India? J Indian Med Assoc. 2009;107(5):288-90, 307.
7. Harries AD, Lawn SD, Getahun H, Zachariah R, Havlir DV. HIV and tuberculosis - science and implementation to turn the tide and reduce deaths. J Int AIDS Soc. 2012;15(2):17396. doi: 10.7448/IAS.15.2.17396.
8. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298.
9. Zachariah R, Teck R, Ascurra O, Gomani P, Manzi M, Humblet P, et al. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi? Int J Tuberc Lung Dis. 2005;9(3):238-47.
10. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85(11):867-72.
11. Edginton M, Enarson D, Zachariah R, Reid T, Satyanarayana S, Bissell K, et al. Why ethics is indispensable for good-quality operational research. Public Health Action. 2012;2(1):21-2.